Highlights
NYSE: AXON       Axon Enterprise Inc
Last Price Today's Change   Day's Range   Trading Volume
184.60   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):471,300
4 Weeks Range:162.76 - 178.38
4 Weeks Price Volatility (%):
103.49%
52 Weeks Range:121.09 - 212.37
52 Weeks Price Volatility (%):
86.92%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Axovant Sciences Ltd. is a clinical-stage biopharmaceutical company. The Company is focused on acquiring, developing and commercializing therapeutics for the treatment of dementia, including Alzheimer's disease and Lewy body dementia. The Company intends to develop a pipeline of product candidates to address the cognitive, functional and behavioral aspects of dementia and related neurological disorders. The Company is focused to develop its lead product candidate, intepirdine, a selective 5-hydroxytryptamine 6 receptor antagonist, for the treatment of Alzheimer's disease and dementia with Lewy bodies (DLB). The Company also focuses on developing nelotanserin, a selective 5-hydroxytryptamine 2A receptor inverse agonist, for the treatment of rapid eye movement (REM) behavior disorder (RBD) in DLB patients, and visual hallucinations in patients with Lewy body dementia. The Company's pipeline also includes RVT-103 and RVT-104.

  Be the first to like this.
 


TOP ARTICLES

1. Risk-On Sent Dollar Lower State of The Markets
2. Daily Futures Trading Strategy 22 October 2021 Where Futures Lies
3. CryptoNews of the Week CryptoNews
4. Strong Earnings Boosted Stocks Up State of The Markets
5. Daily Futures Trading Strategy 21 October 2021 Where Futures Lies
APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

11490 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 DIA 355.960.00 
 DBS 33.580.00 
 DSI 88.730.00 
 DRW 25.850.00 
 DRV 4.180.00 
 DRN 25.810.00 
 DOO 41.4870.00 
 DON 43.790.00 
 DOL 48.5890.00 
 DOG 32.630.00